Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox administration route study for neurogenic detrusor overactivity
2009-012431-15Phase 3Completed
- Sponsor
- Krajská nemocnice Liberec
- Start
- Dec 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of botulinum toxin type A in detrusor hyperreflexia (DH) and overactive bladder (OAB) (2 arms), sponsored by Krajská nemocnice Liberec. Primary endpoint: Primary efficacy of Botox treatment. Started Dec 2009; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
detrusor hyperreflexia (DH)overactive bladder (OAB)
Beyond the preview
Go deeper on 2009-012431-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012431-15.